Schonfeld Strategic Advisors LLC Harvard Bioscience Inc Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.93 - $4.59 $675,500 - $1.61 Million	-350,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.77 - $4.38 $346,250 - $547,500	125,000 Added 55.56%	350,000 $1.51 Million
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $380,568 - $628,000	-125,600 Reduced 35.82%	225,000 $716,000
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $878,000 - $1.17 Million	175,600 Added 100.34%	350,600 $1.84 Million
Q2 2018 Aug 14, 2018	BUY	$4.2 - $5.95 $210,000 - $297,500	50,000 Added 40.0%	175,000 $936,000
Q1 2018 May 15, 2018	BUY	$3.3 - $5.15 $412,500 - $643,750	125,000 New	125,000 $625,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.